diabetes medication glp 1 Comparing Ozempic, Wegovy and Other GLP-1 Drugs Study: Most Patients Can Safely
Description
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health issues.

Patients who combined resistance training with adequate protein intake preserved , and even gained , lean mass while losing over 25% of their body weight on semaglutide

Conclusion In this data sampling of German inpatients, more than one-third of ASCVD patients may qualify for GLP-1 RA therapy due to concomitant diabetes mellitus or obesity

GLP-1 RA use was consistently associated with improvements in headache frequency, weight reduction, and reduced need for acetazolamide or surgical interventions

GLP-1 drugs have become powerful tools for weight loss.A new review looked at what happens a year or more after people stop taking them.

Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.
